Xeris Pharmaceuticals, Inc. added to its board Douglas Baum, co-founder and COO of MacuCLEAR Corp. Baum was the lead in a small group of investors from the Central Texas Angels Network that invested in the Series A round. Board member Shane Brisbin, managing director of Morgan Stanley Private Wealth Management in San Francisco, is also an investor in Xeris. Its third newest board member is Timothy Sullivan, co-founder of Cedar Park-based Mystic Pharmaceuticals Inc.